David Young, Chief Executive Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 10,000 shares at $7.67 ($77K) on 2021-06-23, disclosed to the SEC on 2021-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |